• Chronic Pain
  • Contact
  • Depression
  • Home
  • Privacy Policy
  • PTSD
  • Terms and Conditions
  • Video
Saturday, June 21, 2025
  • Login
Ketamine News
Advertisement
  • Home
  • Depression
    ketamine news

    Bronner’s Magic Soaps Becomes The First Company to Offer Ketamine-Assisted Therapy as Part of Employees’ Health Benefits

    ketamine news

    Popular Soap Company–Dr. Bronner’s– Plans To Explore The Psychedelic Space

    ketamine news

    Psychedelic and Plant Medicine Decriminalization Efforts Spread to the Midwest.

    ketamine news

    What There is to Know About Ketamine vs. Electroconvulsive Therapy (ECT)

    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    ketamine news

    Aggregate Study on the Efficacy of Ketamine to Treat Depression Shows Promising Results.

    Flow Integrative - Christi Myers

    Provider Spotlight – Christi Myers, Flow Integrative

    How To Help A Depressed Person

    How To Help A Depressed Person

  • Chronic Pain
    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    Ketamine: A Paradigm Shift in Pain Management

    Ketamine: A Paradigm Shift in Pain Management

    ketamine treatment for depression

    Amidst An Opioid Crisis, Ketamine Has the Potential To Save Lives

    Ketamine for pain

    Multi-Day Low Dose Ketamine Infusion For The Treatment Of Complex Regional Pain Syndrome

    ketamine for chronic pain

    End Chronic Back Pain with Ketamine for a Fuller Life

    ketamine for pain

    What You Should Know About Rheumatoid Arthritis

    ketamine for pain

    Myofascial Pain Syndrome: Symptoms, Causes, and Treatment

    ketamine for pain

    A sweet reprieve: Ketamine helps to relive phantom limb pain

  • PTSD
    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    veterans day

    Veterans’ Day: What Does PTSD Look Like In Veterans?

    PTSD awareness month

    PTSD Awareness Month: What Can I Do To Help?

    Trump Orders ‘a lot’ of Ketamine for Depressed Veterans

    Will Ketamine Be A Breakthrough Drug for PTSD?

    Ketamine to treat ptsd

    PTSD Sufferers ‘Healed’ With New Ketamine Infusion Therapy?

    ketamine to treat PTSD

    VA Uses Ketamine To Treat PTSD Effectively

    ketamine to treat ptsd

    Ketamine can help treat PTSD

  • Video
  • Ketamine Directory
  • Ketamine Media
  • Contact
No Result
View All Result
  • Home
  • Depression
    ketamine news

    Bronner’s Magic Soaps Becomes The First Company to Offer Ketamine-Assisted Therapy as Part of Employees’ Health Benefits

    ketamine news

    Popular Soap Company–Dr. Bronner’s– Plans To Explore The Psychedelic Space

    ketamine news

    Psychedelic and Plant Medicine Decriminalization Efforts Spread to the Midwest.

    ketamine news

    What There is to Know About Ketamine vs. Electroconvulsive Therapy (ECT)

    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    ketamine news

    Aggregate Study on the Efficacy of Ketamine to Treat Depression Shows Promising Results.

    Flow Integrative - Christi Myers

    Provider Spotlight – Christi Myers, Flow Integrative

    How To Help A Depressed Person

    How To Help A Depressed Person

  • Chronic Pain
    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    Ketamine: A Paradigm Shift in Pain Management

    Ketamine: A Paradigm Shift in Pain Management

    ketamine treatment for depression

    Amidst An Opioid Crisis, Ketamine Has the Potential To Save Lives

    Ketamine for pain

    Multi-Day Low Dose Ketamine Infusion For The Treatment Of Complex Regional Pain Syndrome

    ketamine for chronic pain

    End Chronic Back Pain with Ketamine for a Fuller Life

    ketamine for pain

    What You Should Know About Rheumatoid Arthritis

    ketamine for pain

    Myofascial Pain Syndrome: Symptoms, Causes, and Treatment

    ketamine for pain

    A sweet reprieve: Ketamine helps to relive phantom limb pain

  • PTSD
    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    veterans day

    Veterans’ Day: What Does PTSD Look Like In Veterans?

    PTSD awareness month

    PTSD Awareness Month: What Can I Do To Help?

    Trump Orders ‘a lot’ of Ketamine for Depressed Veterans

    Will Ketamine Be A Breakthrough Drug for PTSD?

    Ketamine to treat ptsd

    PTSD Sufferers ‘Healed’ With New Ketamine Infusion Therapy?

    ketamine to treat PTSD

    VA Uses Ketamine To Treat PTSD Effectively

    ketamine to treat ptsd

    Ketamine can help treat PTSD

  • Video
  • Ketamine Directory
  • Ketamine Media
  • Contact
No Result
View All Result
Ketamine News
Home Esketamine

The U.S. Government Must Ensure Open Access to Ketamine Infusions

Ketamine News by Ketamine News
October 16, 2019
in Esketamine, Featured, Ketamine in The News
0
Ketamine Infusions and US Healthcare
0
SHARES
64
VIEWS
Share on FacebookShare on Twitter

Ketamine, which is a drug most commonly used to induce and maintain anesthesia, was developed in the late 1950s and approved for use in humans in the U.S. in 1970, largely as an anesthetic for battlefield use in the Vietnam War. People began using it recreationally as well, first on the West Coast and, eventually, across the world. Subanesthetic doses, those lower than used medicinally, produce a state characterized by a sense of detachment from one’s body and the external world. As a result, the drug quickly became popular, especially on the dance and music scene in the mid-1980s. It is still used recreationally across the world.

Though no longer administered as frequently, ketamine still has several medical uses. Today, doctors use it as an anesthetic for minor operations in both hospitals and war zones, as well as for postoperative pain management, where it may be used in low doses to reduce morphine use and limit post-op nausea and vomiting. The World Health Organization includes ketamine on its List of Essential Medicines. Possibly as a result of its widespread medicinal use, it remains relatively cheap. Its street price per dose ranges from $20 to $25 on average.

Over the past few years, several studies finally concluded what researchers had suspected for years: Ketamine is effective in treating severe cases of depression, especially those including suicidal ideations. Dr. Kevin Kane, an anesthesiologist at a ketamine clinic in Milwaukee, told CNN that this might be “the biggest breakthrough in mental health in the last 50 years.” He goes on to estimate that ketamine is effective for 70 percent of patients with otherwise treatment-resistant depression.

Depression is a global health issue. Fortunately, ketamine can help combat this epidemic. As such, it is imperative that the U.S. government and governments across the globe impose price caps on the drug in order to ensure that all of those who need it can receive the treatment that may, in fact, save their lives.

At ketamine clinics, doctors administer the drug intravenously, and relief can occur within hours, including the cessation of suicidal ideation. Thus, ketamine-infusion therapy has the possibility to be a life-saving treatment for millions of people every year.

Indeed, earlier this year, the New York Times reported that more than 40 percent of college students in the United States said they felt so depressed that their ability to function was significantly impaired. An estimated 16.2 million adults, or 6.7 percent of the U.S. adult population, suffer from at least one major depressive episode in any given year. Globally, the WHO reported in 2017 that approximately 300 million people suffer from depression.

But the U.S. is already failing in this endeavor. Ketamine has been an extremely cheap drug for much of its existence due to its wide use and the fact that it isn’t covered by a patent. Nonetheless, Janssen, a pharmaceutical company, announced in March 2019 that it had patented the left part of the molecule, esketamine, which was not covered under the original patent, and that its newly FDA-approved nasal spray depression treatment, called Spravato, would be priced at $590 for a 56 mg dose and $885 for an 84 mg dose. For the first month of the treatment, patients receive treatment twice a week with either size dose, leading to a wholesale cost ranging from $4,720 to $6,785. Patients may also need subsequent maintenance doses either weekly or biweekly, adding an additional cost of $2,360 to $3,540 per month.

This, of course, is not necessarily the price that patients will pay. Out-of-pocket costs will depend on a patient’s health insurance plan. But it’s unclear which insurance companies will cover the treatment, nor is it clear how much of the cost they will actually cover. Health insurance companies have fallen short when it comes to mental health care compared to other forms of illness. If the past holds any evidence of the future, ketamine treatments will not be entirely covered by insurance.

As promising as this new treatment may sound, it reveals a sickening reality of the U.S. healthcare system: profits over patients. As students, academics and (for a lot of us) patients, we must pressure the U.S. government to step in and control ketamine prices now before they balloon completely out of control as has so often happened with life-saving drugs and treatments in the past.

Original Article: https://dailynorthwestern.com/2019/10/03/opinion/shirola-the-u-s-government-must-ensure-open-access-to-ketamine-infusions/

 

Tags: HealthcareKetamine for depressionKetamine News
Previous Post

Making My Way Toward Wellness One Ketamine Infusion at a Time

Next Post

‘Nothing less than transformational:’ Ketamine brings relief to people with severe depression

Next Post
artistic portrait of sad woman

'Nothing less than transformational:' Ketamine brings relief to people with severe depression

Browse by Category

  • A Day in the Life
  • Esketamine
  • Featured
  • Ketamine Dictionary
  • Ketamine for Anxiety
  • Ketamine for Depression
  • Ketamine for Pain
  • Ketamine for PTSD
  • Ketamine in The News
  • Ketamine Treatment
  • Mental Health
  • Psychedelic Medicine
  • Suicide Prevention
  • Uncategorized
ketamine news
Privacy Policy | Terms and Conditions

Categories

  • A Day in the Life
  • Esketamine
  • Featured
  • Ketamine Dictionary
  • Ketamine for Anxiety
  • Ketamine for Depression
  • Ketamine for Pain
  • Ketamine for PTSD
  • Ketamine in The News
  • Ketamine Treatment
  • Mental Health
  • Psychedelic Medicine
  • Suicide Prevention
  • Uncategorized

Recent Posts

  • Ketamine Decoded: New Study Sheds Light on Its Powerful Brain and Mood Effects
  • Capturing the Ketamine Experience in Real Time: A First-of-its-Kind Academic Paper from Denovo Therapy
  • A Group of D.C. Advocacy Groups Have Joined Hands to Push For Drug Policy Reform in the Nation’s Capital
  • Connecticut Approves a Bill That Could Pave Way for the Use of Psychedelic Substances to Treat Mental Health Illnesses
  • ‘Magic Mushrooms’ Look Set to Follow in the Footsteps of Cannabis
  • Chronic Pain
  • Contact
  • Depression
  • Home
  • Privacy Policy
  • PTSD
  • Terms and Conditions
  • Video

© 2025 Ketamine News

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Depression
  • Chronic Pain
  • PTSD
  • Video
  • Ketamine Directory
  • Ketamine Media
  • Contact

© 2025 Ketamine News